Chemed Corp (CHE) Revenue-to-Profit Sankey Flow & SEC XBRL Financials
Chemed Corp (CHE) carries a Roarable Rating of C+ (Hold) with 69/100 RQD Confidence. The underlying business is intact, so current owners don’t need to panic-sell—but mixed big-money flow or rich pricing means new buyers can afford to wait for either a pullback or a B-or-higher upgrade.
How CHE Turns Every Dollar of Sales Into Real Bottom-Line Profit
Multi-Year SEC EDGAR XBRL Revenue, Net Profit & Free Cash Flow Trajectory
| Fiscal Year | Revenue | Gross Margin | Op Margin | Net Profit | Free Cash Flow | ROIC % |
|---|---|---|---|---|---|---|
| FY 2025 | $2.53B | 32.5% | 13.4% | $265.2K | $325.5M | 23.1% |
| FY 2024 | $1.53B | -3% | 23.9% | $302.0K | $368.0M | 24.4% |
| FY 2023 | $1.32B | 44% | 25.9% | $272.5K | $271.1M | 11.4% |
Red-Light Warning Desk: How Pros Profit When Overhyped Stocks Crack (Featuring CHE)
- ✓Live walkthrough of CHE's RQD Radar, SEC cash-conversion gap & downside levels
- ✓3 asymmetric Bear/Hedge setups institutions use when 10-year yields stay elevated
- ✓Includes instant 24/7 email alert whenever any of your stocks flip to Red
CHE Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +65.3% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on CHE today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for CHE. Explore sector supply chains on /butterfly.
CHE Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDHow profitable is Chemed Corp (CHE)?
In FY 2025 (10-K), CHE converted $2.5B of revenue into a 32.5% gross margin, 13.4% operating margin, and $325.5M in free cash flow (12.9% FCF margin).